CD177 and neoplasm: The neutrophil-associated marker CD177 is also enriched on Treg cells in renal clear cell carcinoma patients with poor prognoses [184]; antibody-mediated blockade or Treg cell-specific deletion of CD177 decreases Treg cell accumulation in tumors and improves tumor control [184].